BIB — ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (ticker: BIB) is a equity ETF issued by Proshare Advisors LLC tracking NASDAQ Biotechnology Index (200%). It was launched on 2010-04-07.
About BIB
ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that seeks daily investment results, before fees and expenses, that correspond to 200% of the daily performance of the NASDAQ Biotechnology Index. The fund invests in financial instruments such as swap agreements, which are contracts that provide leveraged exposure to the underlying index. This fund may be considered by investors seeking amplified daily returns from the U.S. biotechnology sector. Due to its leveraged nature, BIB is designed for sophisticated investors who actively manage their portfolios and understand the risks associated with daily rebalancing and compounding.
- Tracks 200% of the daily performance of the NASDAQ Biotechnology Index.
- Composed of 265 holdings, primarily derivative instruments like swaps.
- Offers leveraged exposure to U.S. Pharma, Biotech & Life Sciences.
- Expense ratio of 0.95%.
- AUM of $71M with an average daily volume of 9,987.75.
Returns (Total Return)
| Period | Return |
|---|---|
| 1 Day | 3.49% |
| 1 Week | -4.45% |
| 1 Month | -0.50% |
| 3 Months | -4.76% |
| 6 Months | -3.17% |
| YTD | -0.52% |
| 1 Year | 76.31% |
| 3 Years | 49.83% |
| 5 Years | -2.92% |
| 10 Years | — |
| Since Inception | — |
Top Holdings
| # | Security | Symbol | Weight |
|---|---|---|---|
| 1 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 57.05% |
| 2 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 57.05% |
| 3 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 53.00% |
| 4 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 53.00% |
| 5 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 53.00% |
| 6 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 53.00% |
| 7 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 53.00% |
| 8 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 43.99% |
| 9 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 43.99% |
| 10 | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | N/A | 43.99% |
Fund Profile
| Issuer | Proshare Advisors LLC |
|---|---|
| Brand | ProShares |
| Asset Class | equity |
| Strategy | Exchange-specific |
| Structure | ETF |
| Category | Leveraged Equities |
| Segment | Leveraged Equity: U.S. Pharma, Biotech & Life Sciences |
| Sector | Biotechnology |
| Region | North America |
| Index Tracked | NASDAQ Biotechnology Index (200%) |
| Inception Date | 2010-04-07 |
| Tax on Distributions | Ordinary income |
Quick Facts
| Ticker | BIB |
|---|---|
| Full Name | ProShares Ultra Nasdaq Biotechnology |
| Issuer | Proshare Advisors LLC |
| Asset Class | equity |
| Expense Ratio | 0.01% |
| AUM | $66.62M |
| Inception | 2010-04-07 |
| Index Tracked | NASDAQ Biotechnology Index (200%) |
Frequently Asked Questions
What does BIB track?
BIB (ProShares Ultra Nasdaq Biotechnology) tracks NASDAQ Biotechnology Index (200%), a equity benchmark.
What is the expense ratio of BIB?
BIB has an expense ratio of 0.01% per year.
What is the AUM of BIB?
BIB has approximately $66.62M in assets under management.
Does BIB pay a dividend?
BIB distributes income according to its prospectus (Ordinary income tax treatment). Check the dividend history tab for ex-dividend dates and yield.
Who issues BIB?
BIB is issued by Proshare Advisors LLC under the ProShares brand, launched on 2010-04-07.
Open the interactive BIB dashboard for charts, historical fund flows, holdings breakdown and seasonality patterns.